Expired Covid-era approvals are under fire as SC slams the Centre and drug regulator for negligence in antifungal drug approvals.
Read MoreExpired Covid-era approvals are under fire as SC slams the Centre and drug regulator for negligence in antifungal drug approvals.
Read More
Lower drug prices can be achieved by reforming the U.S. patent system. Discover how these changes can impact affordability.
Read More